Stylage L Bi-Soft Lidocaine is a next-generation injectable filler designed to correct moderate to deep wrinkles and restore lost facial volume. This product is ideal for treating skin imperfections in areas such as the nasolabial folds, corners of the mouth, and other regions with pronounced age-related changes. Stylage L Bi-Soft is an enhanced version of the classic Stylage L, with the addition of lidocaine, which significantly improves patient comfort during the procedure.
The filler is produced by Revance Therapeutics, a global leader in the development and manufacturing of aesthetic products. The Stylage brand is known for producing high-quality injectable treatments that deliver long-lasting results and ensure high safety standards.
Composition, Usage, and Application Methods
Composition:
- Hyaluronic Acid: The main active ingredient that restores tissue volume, improves skin hydration, and enhances elasticity. Stylage L contains 18 mg/ml of hyaluronic acid.
- Lidocaine: A local anesthetic added to reduce pain during injections and enhance patient comfort. This helps minimize discomfort during the procedure and the recovery period.
Usage and Application Methods:
Stylage L Bi-Soft is used to correct moderate and deep wrinkles, including:
- Nasolabial folds
- Corners of the mouth and chin lines
- Other areas with noticeable age-related changes
The procedure is performed using injections with a fine needle or cannula. This technique minimizes tissue trauma and reduces the likelihood of bruising and swelling. The product is injected into the middle or deep dermal layers, ensuring long-lasting effects. The procedure should be performed by a qualified specialist in a clinic or a specialized treatment room. Results are visible immediately after the injection, and the effects typically last from 12 to 18 months, depending on individual factors.
Contraindications
Stylage L Bi-Soft Lidocaine has several contraindications that should be considered before use:
- Allergic reaction to any component of the product, including hyaluronic acid or lidocaine.
- Pregnancy and breastfeeding: There are insufficient studies confirming the safety of use during these periods.
- Active inflammatory processes or skin infections in the area of injection.
- Autoimmune diseases, connective tissue disorders, or immune system dysfunction.
- Blood clotting disorders, as well as a tendency to form scars or hypertrophic scars.
- Under 18 years old: The product is not recommended for use in children.
- Allergic reactions to anesthetic agents.
For safe use and optimal results, it is recommended to have a preliminary consultation with a qualified cosmetic doctor who can assess your skin condition and create a personalized treatment plan.
This description is for informational purposes only and is not an instruction for use.
